Dr. Brinson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 E 30th St
Ste 300
Austin, TX 78705Phone+1 512-476-6555Fax+1 512-476-5611
Education & Training
University of Texas at Austin Dell Medical SchoolResidency, Family Medicine, 1990 - 1993
Texas Tech University Health Sciences Center School of MedicineClass of 1990
Certifications & Licensure
TX State Medical License 1991 - 2025- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2012-2013
Clinical Trials
- 12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
- Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Publications & Presentations
PubMed
- 93 citationsBictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 resul...David A. Wohl, Yazdan Yazdanpanah, Axel Baumgarten, Amanda Clarke, Melanie A. Thompson
The Lancet. HIV. 2019-06-01 - 148 citationsCabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1...David A. Margolis, Cynthia Brinson, Graham H R Smith, Jerome De Vente, Debbie Hagins
The Lancet. Infectious Diseases. 2015-10-01 - 261 citationsEfficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiorit...Josep M. Llibre, Chien-Ching Hung, Cynthia Brinson, Francesco Castelli, Pierre-Marie Girard
Lancet. 2018-03-03
Press Mentions
Texas Health Action Names New Chief Medical OfficerJune 8th, 2022- How a COVID-19 Antibody Therapy Being Used in Austin May Be Expanded to Help More PeopleJanuary 7th, 2021
First Clinic Specifically Serving Transgender Needs Opens in AustinMarch 8th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
